Fatty acid-binding proteins as plasma markers of tissue injury.

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov (2008) 5.78

Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int (2009) 1.94

Biomarkers of nephrotoxic acute kidney injury. Toxicology (2008) 1.55

Attenuation of Colitis by Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Defined Microbiota Mouse Model. Dig Dis Sci (2015) 1.48

The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. PLoS Pathog (2013) 1.24

Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clin Med Insights Cardiol (2015) 1.19

Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis. Mol Cell Proteomics (2009) 1.18

Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg (2010) 1.16

Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS One (2011) 1.10

Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One (2008) 1.08

Lipid chaperones and metabolic inflammation. Int J Inflam (2011) 1.03

Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS One (2013) 1.01

Serum adipocyte fatty acid-binding protein levels in patients with critical illness are associated with insulin resistance and predict mortality. Crit Care (2013) 0.99

IL-1α mediated chorioamnionitis induces depletion of FoxP3+ cells and ileal inflammation in the ovine fetal gut. PLoS One (2011) 0.98

Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J Infect Dis (2013) 0.92

Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers. Int Immunopharmacol (2007) 0.92

Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer (2009) 0.90

Non-invasive markers of gut wall integrity in health and disease. World J Gastroenterol (2010) 0.90

Heart-type fatty acid binding protein (H-FABP): relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism. Cardiovasc Diabetol (2011) 0.90

Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease. Gut (2016) 0.90

Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS One (2015) 0.89

Increased expression of fatty-acid and calcium metabolism genes in failing human heart. PLoS One (2012) 0.88

Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome (2016) 0.88

Polyethylene glycol versus dual sugar assay for gastrointestinal permeability analysis: is it time to choose? Clin Exp Gastroenterol (2012) 0.86

Clinical Usefulness of Urinary Fatty Acid Binding Proteins in Assessing the Severity and Predicting Treatment Response of Pneumonia in Critically Ill Patients: A Cross-Sectional Study. Medicine (Baltimore) (2016) 0.86

Role of alpha-actin in muscle damage of injured athletes in comparison with traditional markers. Br J Sports Med (2007) 0.86

Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy. Indian J Nephrol (2015) 0.85

Metabolomic markers for intestinal ischemia in a mouse model. J Surg Res (2012) 0.84

Proteomic analysis of liver in rats chronically exposed to fluoride. PLoS One (2013) 0.84

Delayed onset muscle soreness after inspiratory threshold loading in healthy adults. Cardiopulm Phys Ther J (2010) 0.83

Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes. Histochem Cell Biol (2007) 0.83

Heart-type Fatty acid-binding protein in Acute Myocardial infarction Evaluation (FAME): background and design of a diagnostic study in primary care. BMC Cardiovasc Disord (2008) 0.82

Beneficial effects of flaxseed oil and fish oil diet are through modulation of different hepatic genes involved in lipid metabolism in streptozotocin-nicotinamide induced diabetic rats. Genes Nutr (2012) 0.82

Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study. Stroke (2015) 0.81

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases. Front Aging Neurosci (2011) 0.81

Circulating fatty acid binding protein as a marker of intestinal failure in septic patients. Crit Care (2012) 0.80

Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction. Acta Pharmacol Sin (2010) 0.80

An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome. Clin Biochem Rev (2012) 0.79

Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain. Indian Heart J (2015) 0.79

Comparative study of high sensitivity troponin T and heart-type fatty acid-binding protein in STEMI patients. Saudi J Biol Sci (2014) 0.79

Serum level of heart-type Fatty Acid-binding protein in patients with chronic renal failure. Sultan Qaboos Univ Med J (2009) 0.79

Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome. Biochem Med (Zagreb) (2012) 0.79

Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I. BMC Cardiovasc Disord (2015) 0.79

Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy. Mediators Inflamm (2015) 0.77

The effect of endurance exercise on intestinal integrity in well-trained healthy men. Physiol Rep (2016) 0.77

Comparison of a qualitative measurement of heart-type fatty acid-binding protein with other cardiac markers as an early diagnostic marker in the diagnosis of non-ST-segment elevation myocardial infarction. Cardiovasc J Afr (2015) 0.77

Cytokine balance in hepatosplanchnic system during thoracoabdominal aortic aneurysm repair. J Artif Organs (2011) 0.76

Serum markers in the clinical management of celiac disease. Dig Dis (2015) 0.76

High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation. BMC Cardiovasc Disord (2014) 0.76

Serologic Intestinal-Fatty Acid Binding Protein in Necrotizing Enterocolitis Diagnosis: A Meta-Analysis. Biomed Res Int (2015) 0.76

Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Lipids Health Dis (2015) 0.76

Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program. Alcohol Clin Exp Res (2017) 0.75

Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers. Biomed Res Int (2015) 0.75

Calprotectin: Clinical Applications in Pediatrics. J Pediatr Pharmacol Ther (2016) 0.75

Evaluation of the diagnostic indices and clinical utility of qualitative cardiodetect® test kit in diagnosis of ami within 12 hours of onset of chest pain in the emergency department. Int J Emerg Med (2011) 0.75

Life and death at the mucosal-luminal interface: New perspectives on human intestinal ischemia-reperfusion. World J Gastroenterol (2016) 0.75

Intestinal fatty acid binding protein as a marker for intra-abdominal pressure-related complications in patients admitted to the intensive care unit; study protocol for a prospective cohort study (I-Fabulous study). Scand J Trauma Resusc Emerg Med (2015) 0.75

Prediction of Gut Wall Integrity Loss in Viral Gastroenteritis by Non-Invasive Marker. Open Access Maced J Med Sci (2015) 0.75

Role of H-FABP values in determining the etiologic factors of the cardiac injuries. Pan Afr Med J (2017) 0.75

Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure. Hepatology (2016) 0.75

Heart-type fatty acid-binding protein as a predictor of cardiac ischemia in intractable seizures in children. J Pediatr Neurosci (2016) 0.75

Serum complements and heart fatty acid binding protein in Bangladeshi patients with acute myocardial infarction. Heart Asia (2012) 0.75

Early diagnosis of hollow viscus injury using intestinal fatty acid-binding protein in blunt trauma patients. Medicine (Baltimore) (2017) 0.75

The Impact of Chronic Liver Diseases on the Level of Heart-Type Fatty Acid-Binding Protein (H-FABP) Concentrations. Sultan Qaboos Univ Med J (2009) 0.75

Diagnosis of Non-ST-Elevation Acute Coronary Syndrome by the Measurement of Heart-Type Fatty Acid Binding Protein in Serum: A Prospective Case Control Study. J Biomark (2014) 0.75

Impact of clinical context on acute kidney injury biomarker performances: differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein. Sci Rep (2016) 0.75

Endurance Exercise Increases Intestinal Uptake of the Peanut Allergen Ara h 6 after Peanut Consumption in Humans. Nutrients (2017) 0.75

A Study on the Role of Heart Type Fatty Acid Binding Protein in the Diagnosis of Acute Myocardial Infarction. J Clin Diagn Res (2016) 0.75

Serum H-FABP levels in patients with hypothyroidism. Wien Klin Wochenschr (2014) 0.75

I-FABP is a Novel Marker for the Detection of Intestinal Injury in Severely Injured Trauma Patients. World J Surg (2017) 0.75

Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell derived cardiomyocytes. Br J Pharmacol (2017) 0.75

Does heart-type fatty acid-binding protein predict clinical outcomes after pediatric cardiac surgery? Ann Pediatr Cardiol (2017) 0.75

Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol (2017) 0.75

Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J (2004) 2.37

Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation (2003) 1.96

Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem (2003) 1.85

Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem (2007) 1.74

A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem (2004) 1.58

Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta (2005) 1.40

Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc (2004) 1.38

Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes (2002) 1.38

Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes (2003) 1.37

Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes (2004) 1.35

Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J Physiol (2005) 1.31

Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis. J Biol Chem (2011) 1.30

Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol Cell Biochem (2002) 1.30

Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am J Physiol Endocrinol Metab (2005) 1.29

A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am J Physiol Endocrinol Metab (2007) 1.29

Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res (2008) 1.27

Gene therapy for lipoprotein lipase deficiency: working toward clinical application. Hum Gene Ther (2005) 1.24

Evolution of the family of intracellular lipid binding proteins in vertebrates. Mol Cell Biochem (2002) 1.23

Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. Hum Gene Ther (2004) 1.18

Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am J Physiol Endocrinol Metab (2002) 1.17

Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda) (2007) 1.16

Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J Biol Chem (2009) 1.13

Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender. J Appl Physiol (1985) (2004) 1.11

Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot Essent Fatty Acids (2010) 1.07

Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein. J Immunol Methods (2003) 1.07

AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem Biophys Res Commun (2007) 1.06

Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch (2004) 1.05

In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am J Physiol Endocrinol Metab (2009) 1.05

Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin Chem (2004) 1.04

Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats. Am J Physiol Regul Integr Comp Physiol (2009) 1.02

Crucial role for LKB1 to AMPKalpha2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes. Biochim Biophys Acta (2008) 1.01

Critical steps in cellular fatty acid uptake and utilization. Mol Cell Biochem (2002) 1.00

Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol (2008) 1.00

Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am J Physiol Endocrinol Metab (2004) 0.99

Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J (2003) 0.99

The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett (2005) 0.99

In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation. J Biol Chem (2012) 0.98

Gender-related differences in the metabolic response to fasting. J Clin Endocrinol Metab (2007) 0.98

The effect of UCP3 overexpression on mitochondrial ROS production in skeletal muscle of young versus aged mice. FEBS Lett (2008) 0.98

In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation. J Physiol (2010) 0.98

Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett (2009) 0.98

FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle. Am J Physiol Regul Integr Comp Physiol (2009) 0.97

Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria. J Physiol (2008) 0.97

Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol Cell Biochem (2006) 0.97

Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci U S A (2003) 0.97

Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot Essent Fatty Acids (2008) 0.97

Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle. Am J Physiol Endocrinol Metab (2007) 0.96

Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters. Mol Cell Biochem (2007) 0.95

New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36. Biochem J (2002) 0.95

Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem (2002) 0.95

Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metab (2002) 0.94

Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4. Biochim Biophys Acta (2007) 0.93

High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot Essent Fatty Acids (2011) 0.92

Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle. J Physiol (2007) 0.92

Muscovite (mica) allows the characterisation of supported bilayers by ellipsometry and confocal fluorescence correlation spectroscopy. Biol Chem (2002) 0.92

Overexpression of membrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol Genomics (2004) 0.92

Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity. Am J Physiol Endocrinol Metab (2007) 0.92

Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK. Cell Signal (2007) 0.92

Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered. Am J Physiol Endocrinol Metab (2004) 0.92

Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes. Cell Mol Life Sci (2011) 0.92

Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction. Int J Cardiol (2008) 0.91

Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates. Biochem J (2009) 0.91

Gender differences in pre-hospital time delay and symptom presentation in patients suspected of acute coronary syndrome in primary care. Fam Pract (2011) 0.90

A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism. Am J Physiol Endocrinol Metab (2003) 0.90

Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice. Biochemistry (2005) 0.89

Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice. J Biol Chem (2004) 0.89

Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab (2006) 0.88

Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle. J Physiol (2006) 0.88

Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J Biol Chem (2001) 0.88

Signalling components involved in contraction-inducible substrate uptake into cardiac myocytes. Proc Nutr Soc (2004) 0.87

CD36 is important for adipocyte recruitment and affects lipolysis. Obesity (Silver Spring) (2013) 0.86

Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes. J Endocrinol (2009) 0.86

Significance of uncoupling protein 3 in mitochondrial function upon mid- and long-term dietary high-fat exposure. FEBS Lett (2011) 0.86

Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart. Endocrinology (2009) 0.86

Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury. Biosens Bioelectron (2004) 0.86

Protein-mediated fatty acid uptake: regulation by contraction, AMP-activated protein kinase, and endocrine signals. Appl Physiol Nutr Metab (2007) 0.85

Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia. FASEB J (2005) 0.85

Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats. Biochem J (2003) 0.85

CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes. Biochem J (2012) 0.85

Protein kinase D1 is essential for contraction-induced glucose uptake but is not involved in fatty acid uptake into cardiomyocytes. J Biol Chem (2011) 0.85

FAT/CD36 expression is not ablated in spontaneously hypertensive rats. J Lipid Res (2008) 0.85

Comparison of perfusate activities of glutathione S-transferase, alanine aminopeptidase and fatty acid binding protein in the assessment of non-heart-beating donor kidneys. Ann Clin Biochem (2003) 0.84

Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am J Physiol Endocrinol Metab (2011) 0.84

Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres. Histochem Cell Biol (2004) 0.84

Fatty acid- and cholesterol transporter protein expression along the human intestinal tract. PLoS One (2010) 0.83

Regulation of fatty acid transport and membrane transporters in health and disease. Mol Cell Biochem (2002) 0.82

Detection of brain injury by fatty acid-binding proteins. Clin Chem Lab Med (2005) 0.82

Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta (2006) 0.82

Heart-type Fatty acid-binding protein in Acute Myocardial infarction Evaluation (FAME): background and design of a diagnostic study in primary care. BMC Cardiovasc Disord (2008) 0.82

Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes. J Mol Cell Cardiol (2012) 0.82

Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315. Am J Physiol Heart Circ Physiol (2012) 0.82

Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma. Mol Cell Biochem (2009) 0.81

Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes. Clin Chim Acta (2006) 0.80

Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids. Am J Physiol Endocrinol Metab (2009) 0.80

The responses of fatty acid-binding protein and creatine kinase to acute and chronic exercise in junior rowers. Res Q Exerc Sport (2003) 0.80

Overexpression of vesicle-associated membrane protein (VAMP) 3, but not VAMP2, protects glucose transporter (GLUT) 4 protein translocation in an in vitro model of cardiac insulin resistance. J Biol Chem (2012) 0.79

Purification, immunochemical quantification and localization in rat heart of putative fatty acid translocase (FAT/CD36). Mol Cell Biochem (2006) 0.79